GSBS Student Publications


Enhanced Ii expression after n-butyrate treatment of a P3HR-1 Burkitt's lymphoma subline which does not express HLA-D

GSBS Program

Biochemistry & Molecular Pharmacology



Document Type


Medical Subject Headings

Burkitt Lymphoma; Butyrates; Butyric Acid; Butyric Acids; Cell Line; Genes, MHC Class II; Histocompatibility Antigens Class II; Humans; Intracellular Membranes; Macromolecular Substances; Membrane Proteins; Microsomes


Life Sciences | Medicine and Health Sciences


Treatment of P3HR-1 Burkitt's lymphoma cultured cells with 4 mM n-butyrate for 48 h induced the abundant expression of a 35 000 dalton, microsomal membrane protein which was demonstrated to be the electrophoretically invariant Ii molecule. To prove this point, [35S]methionine-labelled, microsomal membrane proteins or immunoprecipitates of such detergent-solubilized proteins were subjected to electrophoresis either in SDS gels or in two-dimensional, nonequilibrium pH gradient gels. The induced p35 molecule was judged to be Ii by molecular weight and isoelectric characteristics and by immune complex associations. The abundant expression of Ii on butyrate-treated P3HR-1 cells mimicked the high level of expression of p35 or Ii on leukemic cells of a subset of patients with hairy cell leukemia. Alpha and beta chains of the HLA-D complex were absent from the P3HR-1 cell line and present in the Jijoye parent from which mutant P3HR-1 was derived. This relatively simple model can lead to the study of inducible synthesis, processing and expression of Ii, with or without HLA-D alpha and beta chains.

Rights and Permissions

Citation: Hematol Oncol. 1984 Jul-Sep;2(3):239-47.

Related Resources

Link to Article in PubMed

Journal Title

Hematological oncology

PubMed ID


This document is currently not available here.